A missense mutation in hepatocyte nuclear factor-4 alpha, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus. (original) (raw)
Research Article Free access | 10.1172/JCI1403
L Suaud, P Boutin, J C Chèvre, E Durand, A Philippi, F Demenais, N Vionnet, H Furuta, G Velho, G I Bell, B Laine, and P Froguel
Centre National de la Recherche Scientifique (CNRS) EP10-Institute of Biology, Pasteur Institute of Lille & CHRU-Lille, 59019 Lille, France.
Find articles by Hani, E. in:PubMed |Google Scholar
Centre National de la Recherche Scientifique (CNRS) EP10-Institute of Biology, Pasteur Institute of Lille & CHRU-Lille, 59019 Lille, France.
Find articles by Suaud, L. in:PubMed |Google Scholar
Centre National de la Recherche Scientifique (CNRS) EP10-Institute of Biology, Pasteur Institute of Lille & CHRU-Lille, 59019 Lille, France.
Find articles by Boutin, P. in:PubMed |Google Scholar
Centre National de la Recherche Scientifique (CNRS) EP10-Institute of Biology, Pasteur Institute of Lille & CHRU-Lille, 59019 Lille, France.
Find articles by Chèvre, J. in:PubMed |Google Scholar
Centre National de la Recherche Scientifique (CNRS) EP10-Institute of Biology, Pasteur Institute of Lille & CHRU-Lille, 59019 Lille, France.
Find articles by Durand, E. in:PubMed |Google Scholar
Centre National de la Recherche Scientifique (CNRS) EP10-Institute of Biology, Pasteur Institute of Lille & CHRU-Lille, 59019 Lille, France.
Find articles by Philippi, A. in:PubMed |Google Scholar
Centre National de la Recherche Scientifique (CNRS) EP10-Institute of Biology, Pasteur Institute of Lille & CHRU-Lille, 59019 Lille, France.
Find articles by Demenais, F. in:PubMed |Google Scholar
Centre National de la Recherche Scientifique (CNRS) EP10-Institute of Biology, Pasteur Institute of Lille & CHRU-Lille, 59019 Lille, France.
Find articles by Vionnet, N. in:PubMed |Google Scholar
Centre National de la Recherche Scientifique (CNRS) EP10-Institute of Biology, Pasteur Institute of Lille & CHRU-Lille, 59019 Lille, France.
Find articles by Furuta, H. in:PubMed |Google Scholar
Centre National de la Recherche Scientifique (CNRS) EP10-Institute of Biology, Pasteur Institute of Lille & CHRU-Lille, 59019 Lille, France.
Find articles by Velho, G. in:PubMed |Google Scholar
Centre National de la Recherche Scientifique (CNRS) EP10-Institute of Biology, Pasteur Institute of Lille & CHRU-Lille, 59019 Lille, France.
Find articles by Bell, G. in:PubMed |Google Scholar
Centre National de la Recherche Scientifique (CNRS) EP10-Institute of Biology, Pasteur Institute of Lille & CHRU-Lille, 59019 Lille, France.
Find articles by Laine, B. in:PubMed |Google Scholar
Centre National de la Recherche Scientifique (CNRS) EP10-Institute of Biology, Pasteur Institute of Lille & CHRU-Lille, 59019 Lille, France.
Find articles by Froguel, P. in:PubMed |Google Scholar
Published February 1, 1998 -More info
Published February 1, 1998 -Version history
Non-insulin-dependent diabetes mellitus (NIDDM) is a heterogeneous disorder characterized by hyperglycemia resulting from defects in insulin secretion and action. Recent studies have found mutations in the hepatocyte nuclear factor-4 alpha gene (HNF-4alpha) in families with maturity-onset diabetes of the young (MODY), an autosomal dominant form of diabetes characterized by early age at onset and a defect in glucose-stimulated insulin secretion. During the course of our search for susceptibility genes contributing to the more common late-onset NIDDM forms, we observed nominal evidence for linkage between NIDDM and markers in the region of the HNF-4alpha/MODY1 locus in a subset of French families with NIDDM diagnosed before 45 yr of age. Thus, we screened these families for mutations in the HNF-4alpha gene. We found a missense mutation, resulting in a valine-to-isoleucine substitution at codon 393 in a single family. This mutation cosegregated with diabetes and impaired insulin secretion, and was not present in 119 control subjects. Expression studies showed that this conservative substitution is associated with a marked reduction of transactivation activity, a result consistent with this mutation contributing to the insulin secretory defect observed in this family.
- Version 1 (February 1, 1998): No description